Research Peptides
A high-purity research peptide studied in long-acting growth-hormone research. Available in 5mg, with every batch independently tested and dispatched from the UK.
A high-purity research peptide studied in long-acting growth-hormone research. Available in 5mg, with every batch independently tested and dispatched from the UK.
CJC-1295 with DAC UK is Crown Peptides' long-acting synthetic growth-hormone-releasing hormone analogue, available in 5mg strength for laboratory research.
Supplied for laboratory research purposes only — not for human consumption or for medical, veterinary or diagnostic use.
CJC-1295 with DAC is a synthetic analogue of growth-hormone-releasing hormone designed with a Drug Affinity Complex that can bind circulating albumin. The DAC modification is central to its research profile because it changes peptide persistence compared with shorter-acting GHRH analogues such as [Sermorelin].
CJC-1295 with DAC is studied in endocrine research examining GHRH-receptor signalling, pituitary growth-hormone release, and prolonged stimulation of GH and IGF-1 secretion in controlled human research (Learn more). The albumin-binding DAC modification makes the compound particularly useful for comparing short- and long-duration GHRH signalling against peptides like [Ipamorelin] and [Tesamorelin] in controlled models.
Compound-level reference data. Batch-specific results appear on the Certificate of Analysis.
Work out concentration with the peptide calculatorCrown Peptides CJC-1295 with DAC is supplied for controlled laboratory research with batch-specific analytical documentation. High-Performance Liquid Chromatography (HPLC) can assess chromatographic purity, while Mass Spectrometry provides molecular information used to support identity verification.
The batch-specific Certificate of Analysis is the definitive source for the exact purity result, identity data and analytical specification of the material supplied.
Researchers working with CJC-1295 with DAC may also be interested in [CJC-1295 No DAC + Ipamorelin], [Ipamorelin], [GHRP-6], [Sermorelin] and [Tesamorelin] — other growth-hormone-releasing peptides studied in the same endocrine research pathway.
It is a synthetic GHRH analogue incorporating a Drug Affinity Complex designed to extend peptide persistence through albumin binding, supplied by Crown Peptides at 5mg strength.
DAC stands for Drug Affinity Complex. It is the modification responsible for the compound's albumin-binding and longer-duration research profile.
Research centres on GHRH receptor activity, pituitary growth-hormone release, downstream endocrine signalling and peptide pharmacokinetics.
The DAC version is designed for prolonged persistence, whereas the No-DAC form is studied as a shorter-acting GHRH analogue.
Identity and purity are assessed using peptide-appropriate analytical methods such as HPLC and Mass Spectrometry, with exact results on the batch-specific CoA.
Every batch is published openly — identity, purity and batch number, with no account needed.
Supplied for laboratory research purposes only — not for human consumption or for medical, veterinary or diagnostic use.
Each batch undergoes internal analytical verification using chromatographic and spectrometric methods prior to lyophilisation.
• HPLC Analysis
• Mass Spectrometry Confirmation
• Batch Traceability
By purchasing this product you confirm that you are a qualified researcher and that this compound will be used exclusively for laboratory research purposes.
This product is not intended for diagnostic or therapeutic use.
Any human or medical use is strictly prohibited.
Store in a cool, dry, secure and sterile environment away from any unauthorised persons or children.
Disclaimer: All products are sold strictly for laboratory research purposes only. Not for human or veterinary use, consumption, therapeutic, or diagnostic application. By purchasing, you confirm you are a qualified professional and legally permitted to handle these materials in compliance with all applicable laws and regulations. Misuse, resale for unauthorised purposes, or unlawful application is strictly prohibited. Crown Peptides UK disclaims all liability for improper use, handling, or regulatory non-compliance.